Krebs Biochemicals and Industries Limited has informed the Exchange regarding ''.
KREBSBIO · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Krebs Biochemicals has filed a routine compliance update regarding the re-lodgement of physical share transfer requests under a SEBI special window. The Registrar (KFIN Technologies) reported NIL requests received, processed, approved, or rejected during the month of December 2025. The special six-month window for re-lodging physical share transfer requests runs from July 7, 2025 to January 6, 2026. This filing is submitted in line with SEBI Circular dated July 2, 2025. The company remains small-cap with no notable activity in this category during the reporting period.
No material impact on shareholders or stock price. This is a standard regulatory compliance disclosure confirming zero activity in physical share transfers during December 2025.